Cystitis in Females Workup
- Author: John L Brusch, MD, FACP; Chief Editor: Michael Stuart Bronze, MD more...
In the 1980s, many experts felt that urine cultures were unnecessary in young women with probable cystitis because almost all of these were caused by pan-susceptible isolates of Escherichia coli. Since then, however, antibiotic resistance in uropathogenic E coli has become a significant concern. Resistance has also been emerging among other common cystitis pathogens, including Enterococcus faecalis, Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis.
Trimethoprim-sulfamethoxazole (TMP-SMX) resistance has reached levels as high as 20% in some communities. Substitution of fluoroquinolones has resulted in an increase in resistance to these drugs, as well.
Nevertheless, according to guidelines from the American College of Obstetricians and Gynecologists, a urine culture is not required for the initial treatment of women with a symptomatic lower urinary tract infection (UTI) with pyuria or bacteriuria or both. In a United Kingdom study, dipstick diagnosis proved more cost-effective than positive midstream urine culture for targeting antibiotic therapy.
Consider obtaining urine cultures in cases of cystitis in immunosuppressed patients and those with a recent history of instrumentation, exposure to antibiotics, or recurrent infection. Obtaining cultures is also advisable in elderly women, who have a high rate of upper tract involvement.
Microscopic hematuria is found in about half of cystitis cases; when found without symptoms or pyuria, it should prompt a search for malignancy. Other possibilities to be considered in the differential diagnosis include calculi, vasculitis, renal tuberculosis, and glomerulonephritis.
In a developing country, hematuria is suggestive of schistosomiasis. Retention of Schistosoma haematobium eggs and formation of granulomas in the urinary tract can lead not only to hematuria but also to dysuria, bladder polyps and ulcers, and even obstructive uropathies. Schistosomiasis can also be associated with salmonellosis and squamous cell malignancies of the bladder.
Bacteremia is associated with pyelonephritis, corticomedullary abscesses, and perinephric abscesses. Approximately 10-40% of patients with pyelonephritis or perinephric abscesses have positive results on blood culture. Bacteremia is not necessarily associated with a higher morbidity or mortality in women with uncomplicated UTI.
Cervical swabs may be indicated in cases of possible pelvic inflammatory disease.
Visual inspection of the urine is not helpful. Cloudiness of the urine is most often due to protein or crystal presence, and malodorous urine may be due to diet or medication use.
No imaging studies are indicated in the routine evaluation of cystitis. Renal function testing is not indicated in most episodes of UTI, but it may be helpful in patients with known urinary tract structural abnormality or renal insufficiency. Renal function testing also may be helpful in older, particularly ill-appearing hosts or in hosts with other complications.
A study of 196 women with painful and/or frequent urination found that most could be classified as having a low or high risk for UTI by asking the following questions[16, 17] :
Does the patient think she has a UTI?
Is there at least considerable pain on urination?
Is there vaginal irritation?
History correctly classified 56% of patients as having a UTI risk of either less than 30% or more than 70%, and adding urine dipstick results increased this correct classification rate to 73%. Correct classification increased to 83% when patients with intermediate risk (30-70%) after history alone underwent an additional test. The strongest indicators of UTI were the patient's suspicion of having a UTI and a positive nitrite test.[16, 17]
The most accurate method to measure pyuria is counting leukocytes in unspun fresh urine using a hemocytometer chamber; greater than 10 white blood cells (WBCs)/mL is considered abnormal. Counts determined from a wet mount of centrifuged urine are not reliable measures of pyuria. A noncontaminated specimen is suggested by a lack of squamous epithelial cells. Pyuria is a sensitive (80-95%) but nonspecific (50-76%) sign of UTI.
White cell casts may be observed in conditions other than infection, and they may not be observed in all cases of pyelonephritis. If the patient has evidence of acute infection and white cell casts are present, however, the infection likely represents pyelonephritis. A spun sample (5 mL at 2000 revolutions per min [rpm] for 5 min) is best used for evaluation of cellular casts.
Proteinuria is commonly observed in infections of the urinary tract, but the proteinuria usually is low grade. More than 2 g of protein per 24 hours suggests glomerular disease.
Approximately 70% of patients with corticomedullary abscesses have abnormal urinalysis findings, whereas those with renal cortical abscesses usually have normal findings. Two thirds of patients with perinephric abscesses have an abnormal urinalysis.
Urine specimen collection
Urine specimens may be obtained by midstream clean catch, suprapubic aspiration, or catheterization.
The midstream-voided technique is as accurate as catheterization if proper technique is followed. Instruct the woman to remove her underwear and sit facing the back of the toilet. This promotes proper positioning of the thighs.
Instruct the patient to spread the labia with one hand and cleanse from front to back with povidone-iodine or soaped swabs with the other hand; then pass a small amount of urine into the toilet; and finally urinate into the specimen cup. The use of a tampon may allow a proper specimen if heavy vaginal bleeding or discharge is present.
Midstream urine specimens may become contaminated, particularly if the woman has difficulty spreading and maintaining separation of the labia. The presence of squamous cells and lactobacilli on urinalysis suggests contamination or colonization (see image below). Catheterization may be needed in some women to obtain a clean specimen, although it poses the risk of iatrogenic infection.
Although the use of midstream urine specimens is widely advocated, one randomized trial in young women showed that the rate of contamination was nearly identical among those who used midstream clean-catch technique and those who urinated into a container without cleansing the perineum or discarding the first urine output. Use of a vaginal tampon in addition to clean-catch technique had no significant effect on the contamination rate.
Dipstick testing should include glucose, protein, blood, nitrite, and leukocyte esterase. Leukocyte esterase is a dipstick test that can rapidly screen for pyuria; it is 57-96% sensitive and 94-98% specific for identifying pyuria. Given this broad range of sensitivity, it is important to consider the possibility of false-positive results, particularly with asymptomatic patients undergoing evaluation for recurrent UTI.
Pyuria, as indicated by a positive result of the leukocyte esterase dipstick test, is found in the vast majority of patients with UTI. This is an exceedingly useful screening examination that can be performed promptly in any ED setting. If pyuria is absent, the diagnosis of UTI should be questioned until urine culture results become available.
In a United Kingdom study, dipstick diagnosis based on findings of nitrite or both leukocyte esterase and blood was 77% sensitive and 70% specific, with a positive predictive value of 81% and a negative predictive value of 65%. Diagnosis on clinical grounds proved less sensitive.
A microscopic evaluation of the urine sample for WBC counts, RBC counts, and cellular or hyaline casts should be performed. In the office, a combination of clinical symptoms with dipstick and microscopic analysis showing pyuria and/or positive nitrite and leukocyte esterase tests can be used as presumptive evidence of UTI.
Low-level pyuria (6-20 WBCs per high-power field [hpf] microscopy on a centrifuged specimen) may be associated with an unacceptable level of false-negative results with the leukocyte esterase dipstick test, as Propp et al found in an ED setting.
In females with appropriate symptoms and examination findings suggestive of UTI, urine microscopy may be indicated despite a negative result of the leukocyte esterase dipstick test. Current emphasis in the diagnosis of UTI rests with the detection of pyuria. As noted, a positive leukocyte esterase dipstick test suffices in most instances.
According to Stamm et al, levels of pyuria as low as 2-5 WBCs/hpf in a centrifuged specimen are important in females with appropriate symptoms. The presence of bacteriuria is significant. However, the presence of numerous squamous epithelial cells raises the possibility of contamination. Low-level or, occasionally, frank hematuria may be noted in otherwise typical UTI; however, its positive predictive value is poor.
Nitrate tests detect the products of nitrate reductase, an enzyme produced by many bacterial species. These products are not present normally unless a UTI exists. This test has a sensitivity and specificity of 22% and 94-100%, respectively. The low sensitivity has been attributed to enzyme-deficient bacteria causing infection or low-grade bacteriuria.
A positive result on the nitrate test is highly specific for UTI, typically because of urease-splitting organisms, such as Proteus species and, occasionally, E coli; however, it is very insensitive as a screening tool, as only 25% of patients with UTI have a positive nitrate test result.
Urine culture remains the criterion standard for the diagnosis of UTI. Collected urine should be sent for culture immediately; if not, it should be refrigerated at 4°C. Two culture techniques (dip slide, agar) are widely used and accurate.
The 2010 Infectious Disease Society of America (IDSA) consensus limits for cystitis and pyelonephritis in women are more than 1000 colony-forming units (CFU)/mL and more than 10,000 CFU/mL, respectively, for clean-catch midstream urine specimens. Historically, the definition of UTI was based on the finding at culture of 100,000 CFU/mL of a single organism. However, this misses up to 50% of symptomatic infections, so the lower colony rate of greater than 1000 CFU/mL is now accepted.
The definition of asymptomatic bacteriuria still uses the historical threshold. Asymptomatic bacteruria in a female is defined as a urine culture (clean-catch or catheterized specimen) growing greater than 100,000 CFU/mL in an asymptomatic individual.
Note that any amount of uropathogen grown in culture from a suprapubic aspirate should be considered evidence of a UTI. Approximately 40% of patients with perinephric abscesses have sterile urine cultures.
An uncomplicated UTI (cystitis) does not require a urine culture unless the woman has experienced a failure of empiric therapy. Obtain a urine culture in patients suspected of having an upper UTI or a complicated UTI, as well in those in whom initial treatment fails.
If the patient has had a UTI within the last month, relapse is probably caused by the same organism. Relapse represents treatment failure. Reinfection occurs in 1-6 months and usually is due to a different organism (or serotype of the same organism). Obtain a urine culture for patients who are reinfected.
If a Gram stain of an uncentrifuged, clean-catch, midstream urine specimen reveals the presence of 1 bacterium per oil-immersion field, it represents 10,000 bacteria/mL of urine. A specimen (5 mL) that has been centrifuged for 5 minutes at 2000 rpm and examined under high power after Gram staining will identify lower numbers. In general, a Gram stain has a sensitivity of 90% and a specificity of 88%.
Complete Blood Cell Count
A CBC is not helpful in differentiating upper from lower UTI or in making decisions regarding admission. However, significant leukopenia in hosts who are older or immunocompromised may be an ominous finding.
The WBC count may or may not be elevated in patients with uncomplicated UTI, but it is usually elevated in patients with complicated UTIs. Patients with complicated UTIs may have anemia; for example, anemia is observed in 40% of patients with perinephric abscesses.
Catheterization is indicated if the patient cannot void spontaneously, if the patient is too debilitated or immobilized, or if obesity prevents the patient from obtaining a suitable specimen. Measurement of postvoiding residual urine volume by catheterization may reveal urinary retention in a host with a defective bladder-emptying mechanism.
Measurement of the postvoid residual volume should be strongly considered in all patients who require hospital-level care. Handheld portable bladder scans may also be used as a noninvasive alternative.
Guidelines from the Centers for Disease Control and Prevention (CDC) advise that in acute care hospital settings, aseptic technique and sterile equipment for catheter insertion must be used to minimize the risk of catheter-associated UTI. Only properly trained individuals who are skilled in the correct technique of aseptic catheter insertion and maintenance should take on this task.
For more information on this procedure, see the Medscape Reference article Urethral Catheterization in Women.
Patients with Spinal Cord Injury
Diagnosing a UTI in a patient with a spinal cord injury is difficult. In patients with SCI, signs and symptoms suggestive of a UTI are malodorous and cloudy urine, muscular spasticity, fatigue, fevers, chills, and autonomic instability.
In these patients, suprapubic aspiration of the bladder is the criterion standard for diagnosing a UTI, although it is not performed often in clinical practice.
For more information on this topic, see the Medscape Reference article Urinary Tract Infections in Patients with Spinal Cord Injury.
Patients with Diabetes Mellitus
Patients with diabetes are at risk for complicated UTIs, which may include renal and perirenal abscess, emphysematous pyelonephritis, emphysematous cystitis, fungal infections, xanthogranulomatous pyelonephritis, and papillary necrosis.
For more information, see the Medscape Reference topic Urinary Tract Infections in Diabetes Mellitus.
Cystitis Caused by Candida
Cystitis caused by Candida is clinically similar to cystitis from other pathogens. The presence of fungus in the urine should be verified by repeating the urinalysis and urine culture. Other features of diagnosis are as follows :
Pyuria is a nonspecific finding
C glabrata may be differentiated from other species by morphology
Candida casts in the urine indicate renal candidiasis but are rarely seen
Colony counts have not proved diagnostically useful
Ultrasonography of the kidneys and collecting systems is the preferred initial study in symptomatic or critically ill patients with candiduria, but computed tomography is better for detecting pyelonephritis or perinephric abscess.
[Guideline] Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011 Mar. 52(5):e103-20. [Medline]. [Full Text].
[Guideline] Wagenlehner FM, Schmiemann G, Hoyme U, Fünfstück R, Hummers-Pradier E, Kaase M, et al. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients]. Urologe A. 2011 Feb. 50(2):153-69. [Medline]. [Full Text].
Abrahamian FM, Moran GJ, Talan DA. Urinary tract infections in the emergency department. Infect Dis Clin North Am. 2008 Mar. 22(1):73-87, vi. [Medline].
Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes JA, et al. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess. 2009 Mar. 13(19):iii-iv, ix-xi, 1-73. [Medline].
Lane DR, Takhar SS. Diagnosis and management of urinary tract infection and pyelonephritis. Emerg Med Clin North Am. 2011 Aug. 29(3):539-52. [Medline].
Czaja CA, Stamm WE, Stapleton AE, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis. 2009 Aug 15. 200(4):528-36. [Medline].
Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011 Mar. 86(3):250-9. [Medline]. [Full Text].
[Guideline] Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1. 50(5):625-63. [Medline]. [Full Text].
Tiemstra JD, Chico PD, Pela E. Genitourinary infections after a routine pelvic exam. J Am Board Fam Med. 2011 May-Jun. 24(3):296-303. [Medline].
Hsiao CJ, Cherry DK, Beatty PC, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2007 summary. Natl Health Stat Report. 2010 Nov 3. 1-32. [Medline].
Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008 Nov. 54(5):1164-75. [Medline].
Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ. 2010 Feb 5. 340:b5633. [Medline]. [Full Text].
Molander U, Arvidsson L, Milsom I, Sandberg T. A longitudinal cohort study of elderly women with urinary tract infections. Maturitas. 2000 Feb 15. 34(2):127-31. [Medline].
Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med. 2008 Oct. 121(10):876-84. [Medline].
[Guideline] American College of Obstetricians and Gynecologists (ACOG). 2008. Treatment of urinary tract infections in nonpregnant women. Available at http://guideline.gov/content.aspx?id=12628. Accessed: September 22, 2010.
Barclay L. Urinary Tract Infection: 3 Questions Aid Diagnosis in Women. Medscape Medical News. Available at http://www.medscape.com/viewarticle/810667. Accessed: September 16, 2013.
Knottnerus BJ, Geerlings SE, Moll van Charante EP, Ter Riet G. Toward a simple diagnostic index for acute uncomplicated urinary tract infections. Ann Fam Med. 2013 Sep-Oct. 11(5):442-51. [Medline]. [Full Text].
Schaeffer AJ, Schaeffer EM. Infections of the Urinary Tract. In: McDougal WS, Wein AJ, Kavoussi LR, et al, eds. Campbell-Walsh Urology. 10th Ed. Philadelphia, PA: Elsevier Saunders; 2012. 46-55.
Lifshitz E, Kramer L. Outpatient urine culture: does collection technique matter?. Arch Intern Med. 2000 Sep 11. 160(16):2537-40. [Medline].
Propp DA, Weber D, Ciesla ML. Reliability of a urine dipstick in emergency department patients. Ann Emerg Med. 1989 May. 18(5):560-3. [Medline].
Mehnert-Kay SA. Diagnosis and Management of Uncomplicated Urinary Tract Infections. American Family Physician. August 1, 2005. 27/No.3:1-9. [Full Text].
[Guideline] Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010 Apr. 31(4):319-26. [Medline]. [Full Text].
Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinary tract infections--diagnosis. Clin Infect Dis. 2011 May. 52 Suppl 6:S452-6. [Medline].
Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009 Feb. 58(2):91-102. [Medline].
Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010 Dec. 7(12):653-60. [Medline].
Little P, Moore MV, Turner S, Rumsby K, Warner G, Lowes JA, et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010 Feb 5. 340:c199. [Medline]. [Full Text].
Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract. 2002 Sep. 52(482):729-34. [Medline]. [Full Text].
Bleidorn J, Gágyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial. BMC Med. 2010 May 26. 8:30. [Medline]. [Full Text].
Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother. 2009 Mar. 53(3):1285-6. [Medline]. [Full Text].
McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc. 2011 Jun. 86(6):480-8. [Medline]. [Full Text].
Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010 Sep. 65(9):1862-77. [Medline]. [Full Text].
[Guideline] Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005 Mar 1. 40(5):643-54. [Medline]. [Full Text].
Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B. Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin Infect Dis. 2009 Aug 15. 49(4):491-7. [Medline]. [Full Text].
Beerepoot MA, ter Riet G, Nys S, et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med. 2011 Jul 25. 171(14):1270-8. [Medline].
Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008 Jan 23. CD001321. [Medline].
Tempera G, Corsello S, Genovese C, Caruso FE, Nicolosi D. Inhibitory activity of cranberry extract on the bacterial adhesiveness in the urine of women: an ex-vivo study. Int J Immunopathol Pharmacol. 2010 Apr-Jun. 23(2):611-8. [Medline].
De Vita D, Giordano S. Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J. 2012 Dec. 23(12):1707-13. [Medline].
van der Starre WE, van Nieuwkoop C, Paltansing S, et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2011 Mar. 66(3):650-6. [Medline].
Cunha BA. Prophylaxis for recurrent urinary tract infections: nitrofurantoin, not trimethoprim-sulfamethoxazole or cranberry juice. Arch Intern Med. 2012 Jan 9. 172(1):82; author reply 82-3. [Medline].
Cunha BA, Schoch PE, Hage JR. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections. Mayo Clin Proc. 2011 Dec. 86(12):1243-4; author reply 1244. [Medline]. [Full Text].
Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med. 2010 Apr 12. 170(7):617-21. [Medline].
Hand L. Urinary Infections: Report Offers Long-Needed Clarity. Medscape [serial online]. Available at http://www.medscape.com/viewarticle/814305. Accessed: November 18, 2013.
Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013 Nov 14. 369(20):1883-91. [Medline].
Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med. 1994 May. 12(3):271-8. [Medline].
Turner D, Little P, Raftery J, Turner S, Smith H, Rumsby K, et al. Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial. BMJ. 2010 Feb 5. 340:c346. [Medline]. [Full Text].
Patients with complicated cystitis who can tolerate oral therapy may be treated with the following options:
Patients who cannot tolerate oral therapy as outlined above or patients with infection that is suspected to be due to resistant organisms should be treated with parenteral therapy, as follows:
Parenteral therapy can be switched to oral therapy once clinical improvement is observed.
Parenteral therapy can be switched to oral therapy once clinical improvement is observed.